PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Cholesterol drug may have role in treating prostate cancer

Crestor suppressed human cancer cells transplanted to mice

2010-09-20
(Press-News.org) TORONTO, Ont., Sept. 20, 2010 – A drug commonly prescribed for people with high cholesterol may also be effective in treating prostate cancer, according to new research by Dr. Xiao-Yan Wen at St. Michael's Hospital.

Rosuvastatin—a statin drug sold as Crestor—suppressed the growth of transplanted human prostate cancer cells in mice.

"Our data provided solid pre-clinical evidence and a strong rationale for clinical trials of statins in the treatment of prostate cancer," said Wen, whose research appears in the September issue of European Urology, the journal of the European Association of Urology.

Prostate cancer is the most common cancer in Canadian men – one in seven men will develop the disease during his lifetime and one in 27 will die from it. Despite improvements in treatments such as surgery, radiation and chemotherapy, many patients still progress to advanced stages.

Recent clinical trials have shown encouraging results regarding the use of angiogenic inhibitors—substances that prevent the growth of blood vessels that feed tumors.

Wen and his colleagues in Canada and China screened 2,000 small molecules in zebrafish embryos with 2,000 small molecules. Seven compounds—four of them statins—slowed or prevented the growth of those blood vessels. They then decided to investigate the cancer-fighting potential of one of those statins, rosuvastatin, and found it suppressed the growth of prostate cancer in mice without apparent side effects.

If human trials confirmed that statin drugs can optimize the benefits of radiation, that would help doctors determine the most effective, less toxic and affordable treatments for their prostate cancer patients.

INFORMATION:

About St. Michael's Hospital

St. Michael's Hospital provides compassionate care to all who enter its doors. The Hospital also provides outstanding medical education to future health care professionals in more than 23 academic disciplines. Critical care and trauma, heart disease, neurosurgery, diabetes, cancer care and care of the homeless are among the hospital's recognized areas of expertise. Through the Keenan Research Centre and the Li Ka Shing Knowledge Institute, research at St. Michael's Hospital is recognized and put into practice around the world. Founded in 1892, the hospital is fully affiliated with the University of Toronto.

For more information, please contact:

Leslie Shepherd
Senior Public Relations Specialist
St. Michael's Hospital
Phone: 416-864-6094 or 647-300-1753
www.stmichaelshospital.com

END



ELSE PRESS RELEASES FROM THIS DATE:

Study: Privacy key obstacle to adopting electronic health records

2010-09-20
The United States could achieve significant health care savings if it achieved widespread adoption of electronic health records (EHRs), but insufficient privacy protections are hindering public acceptance of the EHR concept, according to a new paper from researchers from North Carolina State University. The paper outlines steps that could be taken to boost privacy and promote the use of EHRs. "Electronic health records could reduce costs in the U.S. by an estimated $80 to 100 billion each year," says Dr. David Baumer, head of the business management department at NC State ...

Kids and diabetes risk: Do chromosomes hold new clues?

2010-09-20
Children who have a high risk of developing type 2 diabetes might be identified earlier by way of tell-tale genetic indicators known as biomarkers. Some of those new biomarkers might be pinpointed in research led by Nancy F. Butte and funded by the U.S. Department of Agriculture (USDA) and the U.S. Department of Health and Human Service's National Institutes of Health. Butte is with the USDA Agricultural Research Service (ARS) Children's Nutrition Research Center at Baylor College of Medicine in Houston, Texas, where she is a professor of pediatrics. ARS is USDA's principal ...

Plague researchers race to beat bioterrorists

Plague researchers race to beat bioterrorists
2010-09-20
Saranac Lake, N.Y. – Given the many pressing concerns of the day, fear of plague probably isn't what causes most Americans to lose sleep. But for those whose responsibility it is to combat bioterrorism, plague is among the highest priorities. Those charged with that mission include scientists like medical researcher Steve Smiley, whose lab at the Trudeau Institute is working to develop a vaccine that will protect the public against weaponized forms of plague. The Institute, which is dedicated to studying how the immune system responds to infectious diseases, is at the forefront ...

No pain in the hospital -- wishful thinking or reality?

2010-09-20
More than 80% of hospitalized patients suffer more severe pain than necessary. This is the conclusion of Christoph Maier (Bochum University Hospital, Bochum, Germany) and his coauthors in their interim report of the Pain-Free Hospital Project ("Schmerzfreies Krankenhaus"), which appears in the current issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2010; 107[36]: 607-14). The project, which was initiated in 2003, has the goal of improving pain management in hospitals across Germany. To study the quality of pain therapy, the authors evaluated anonymous ...

Fidgety children are on the rise

2010-09-20
Hyperkinetic disorders among children and adolescents are becoming increasingly common. In the current issue of Deutsches Ärzteblatt International, Ingrid Schubert of the PMV Research Group at the University of Cologne and her colleagues address the question how this has affected the frequency of prescriptions for methylphenidate, a stimulant drug that is used to treat such disorders (Dtsch Arztebl Int 2010; 107[36]: 615¬21). The authors analyzed data concerning tens of thousands of persons insured by the AOK health insurance company in the German state of Hesse over the ...

Effects of chemoradiation therapy by using capecitabine on gastric cancer patients

2010-09-20
Gastric cancer is a major cause of cancer deaths in the world. The outcome of large gastric tumors and those with lymph node involvement remains poor after surgical resection. The optimal adjuvant therapy after surgical resection remains to be determined. The most common strategies in the adjuvant treatment of gastric cancers include fluoropyrimidine-based chemotherapy with or without radiation. The introduction of capecitabine has largely replaced continuous-infusion 5-fluorouracil (5-FU) owing to its ease of administration. However, its efficacy is not proven in randomized ...

How to control massive bleeding from the hepatic artery

2010-09-20
Delayed hepatic arterial hemorrhage after pancreaticoduodenectomy (PD) is not a common but a fatal complication, occurring in 7% of all patients. Its ideal management remains unclear and controversial. A research article published on August 7, 2010 in the World Journal of Gastroenterology addresses this question. The authors reported the clinical outcome of 9 patients with life-threatening hemorrhage from a ruptured hepatic artery pseudoaneurysm after PD after treatment with a new interventional technique, namely placement of stent-grafts. This technique provides a good ...

New options for enteral nutrition in patients with severe acute pancreatitis

2010-09-20
Severe acute pancreatitis (SAP) requires an adequate nutritional support. Enteral nutrition (EN) should be preferred to total parenteral nutrition in patients with SAP, as it is associated with reduced mortality and complications. However, in clinical practice EN is employed far less frequently than it should. The main obstacle to EN diffusion is that it is considered complicated, as to ensure full pancreatic rest, nutrition tubes should be placed in the jejunum, requiring often troublesome procedures. In the past few years, it has been proposed that EN through nasogastric ...

Serious hockey injuries among young children skyrocketing, study finds

2010-09-20
COLUMBUS, Ohio – The incidence of hockey-related injuries among children aged 9 to 14 leading to emergency department visits more than doubled between 1990 and 2006, according to a new nationwide study. There were 2,935 hockey injuries treated in emergency departments in that age group in 1990, increasing to 7,713 in 2006 – an increase of 163 percent. The injury incidence among teens aged 15 to 18 didn't increase as much as that of younger children, but still grew 85 percent during the same time period. The startling increase in injuries calls for more attention to ...

U of M research shows US teen hearing loss is much lower than has been widely reported

2010-09-20
New research from University of Minnesota hearing scientists shows that fewer than 20 percent of teenagers in the United States have a hearing loss as a result of exposure to loud sounds, thus offering a different analysis of data reported in the Journal of the American Medical Association (JAMA) in August. The U of M's research, forthcoming in the Journal of Speech, Language, and Hearing Research, points out that the small hearing losses that audiologist are trying to identify with conventional hearing tests are subject to measurement error and that as many as 10 percent ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] Cholesterol drug may have role in treating prostate cancer
Crestor suppressed human cancer cells transplanted to mice